haematology general-medicine
Padua Prediction Score for VTE Prophylaxis
Predicts risk of VTE in hospitalised medical patients. Score ≥4 defines high-risk patients who benefit from pharmacological thromboprophylaxis. Validated prospectively.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Propranolol (Migraine Prevention) · Beta-Blocker — Migraine Prophylaxis
- Enoxaparin (VTE in Pregnancy) · Low Molecular Weight Heparin (LMWH) — VTE Prophylaxis/Treatment
- Aspirin (Low-Dose — Pre-eclampsia Prevention) · Antiplatelet — Pre-eclampsia Prophylaxis
- Enoxaparin (Orthopaedic VTE Prophylaxis) · Low Molecular Weight Heparin (LMWH)
- Enoxaparin (VTE Prophylaxis — Post-Surgery) · Low Molecular Weight Heparin (LMWH) — VTE Prophylaxis
- Betrixaban (Extended VTE Prophylaxis — Medical Patients) · Oral Factor Xa Inhibitor (DOAC — Extended Duration)
Pathways
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Anaemia Investigation · BSH / NICE
- Splenomegaly Workup · BSH; BMJ Best Practice
- Deep Vein Thrombosis Diagnosis and Treatment · NICE CG144 / NICE NG158
- Sickle Cell Crisis · BSH 2021 / BCSH
- Neutropenic Sepsis · NICE CG151 2012 / ESMO
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.